Rocket Lab's Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes

Key Points

• Rocket Lab reported 73% year-over-year revenue growth and a record $3.6 billion backlog in the third quarter.
• Rocket Lab's technical indicators suggest a possible reversal, but its Neutron rocket is not expected to debut before 2027.
• Rocket Lab retains a Moderate Buy analyst consensus, although recent price-target cuts and continued losses present risks.

Rocket Lab NASDAQ: RKLB shares tanked more than 7% at one point in after-hours trading following an otherwise good Q3 report. The move suggests the market stalled on lift-off, as RKLB was poised to rebound ahead of the release, but don’t read too much into it. Investors should note that strong results were expected and delivered, suggesting a potential sell-the-news/buy-the-dip scenario with shares trading well below their recent highs.

Rocket Lab's Technical Indicators Point to a Potential Reversal

Technical indicators align with a potential rebound that could take this market to all-time highs, if the stars align. Alignment equates to strategic execution, which is apparent in the release, with backlogs swelling and visibility improving. Among the developing signals is a Strong Buy signal in the Stochastic Oscillator across not one but two time frames, and potentially a third, assuming no major business hiccups, hurdles, or setbacks arise.

Stochastic is interesting because it seeks to find order in chaos. The assumption is that day-to-day price swings are random, but the daily movement will trend in one direction or another over time, depending on the fundamentals in play.

In this framework, a series of bullish crossovers low in the stochastic range, reflecting buying and firming support as troughs progress higher, differentiates the Strong Buy signal from the Weak Buy signal. The first bullish crossover is a Weak Signal and far less reliable on its own; to be Strong, the signal must repeat at least twice and be confirmed by other indicators, which the MACD Histogram currently supports on the daily chart. MACD, or Moving Average Convergence Divergence, measures market momentum, signaling whether bulls or bears are in control and whether they are gaining or losing strength.

Bullish MACD crossovers on the daily chart echo the stochastic signals, setting the market up for a bullish momentum swing on the weekly chart. The weekly chart is the linchpin, with MACD not yet reflecting a bullish crossover but moving in the right direction. If it swings positive, the signal would gain further confirmation for technical traders and investors and may trigger a larger, more sustained capital influx.

Rocket Lab's Monthly Chart and Growing Backlog Support the Bullish Case

With signals developing on the daily and weekly charts, investors and traders could see a substantial movement if and when the signal completes. The monthly chart provides the runway in this scenario, as it also reflects a deeply oversold market with the potential to bottom and reverse. Signs of strength on this view include rising market volume and MACD convergence in an uptrend, which could point to a retest of existing highs, if not the setting of fresh highs. Of course, this is all theoretical without a fundamental driver, which the company is happy to provide.

Rocket Lab showed the strength of its vertically integrated space business, reporting nearly 73% year-over-year revenue growth and beating the Q3 consensus by more than 4%. Launch and systems sales drove strength, with industry-wide capacity constraints underpinning price realization. The only bad news is that losses were larger than expected, but execution offset it. The company is advancing across all business lines and actively pursuing its major acquisition of Iridium Communications, which would bring an operational, profitable low-Earth-orbit constellation into the portfolio if the transaction closes.

Backlogs and guidance are the catalysts. Backlog swelled by 52% sequentially, driven by nearly $1 billion in new launch contracts, bringing the total launch backlog to 117 launches, including several for the Neutron rocket. The first Neutron launch is targeted for no earlier than 2027, with future revenue growth and margin improvements depending on successful development and launches. Backlog stood at $3.6 billion as of Q3’s end, equivalent to more than three years of revenue at the Q3 pace, although the timing of that revenue remains uncertain.

Price Targets Fall, But Analysts Remain Bullish on Rocket Lab

Analysts responded with mixed sentiment, highlighting the record Q3 revenue, backlog growth, and guidance alongside the wider losses. While the positives kept sentiment firm at Moderate Buy, the negatives led to some price target reductions, which undercut market appetite. Factors investors should consider, and factors underpinning the bullish outlook, include coverage from 24 analysts, 18 of whom rate the stock Buy or Strong Buy. Another factor is the roughly 70% upside to the consensus price target of about $100, along with upcoming catalysts.

Rocket Lab’s catalysts center on its backlog growth and contract conversion because they could reduce uncertainty in the outlook and drive robust revenue growth. Analysts forecast growth to slow as early as next year, a potential headwind for the stock, but this is partly due to the law of large numbers and the company’s rapid advance. Even so, revenue is forecast to grow about 40% in 2027, and sustaining a compound annual growth rate of about 30% over the next decade could allow the business to grow by more than 1,000% and potentially reach adjusted profitability within the next year or two.